Whole Blood use
No sample preparation needed
Time to result 20 minutes
with hands-on time under 3 minutes
Up to three analytes tested in a single run
Fast & fully automated
Built-in self-test feature to minimize hands-on maintenance
Portable & user friendly
Compact and easy to move with minimal user interaction
Results can be printed or directly transferred to LIMS
|IVR-IB62||IB10 sphingotest® penKid®|
|IVR-IB61||IB10 sphingotest® bio-ADM®|
|IVR-IB58||IB10 sphingotest® DPP3|
Dipeptidyl Peptidase 3
|IVR-IB65||IB10 sphingotest® PCT|
|IVR-IB50||IB10 sphingotest® Troponin-99|
|IVR-IB52||IB10 sphingotest® D-Dimer|
|IVR-IB56||IB10 sphingotest® NT-proBNP|
|IVR-IB53||IB10 sphingotest® Shortness of Breath|
D-Dimer, NT-proBNP, Troponin I
|IVR-IB51||IB10 sphingotest® 3-in-1 Cardiac|
Troponin I, CK-MB, Myoglobin
|IVR-IB55||IB10 sphingotest® TSH|
|IVR-IB54||IB10 sphingotest® beta-hCG|
NOT AVAILABLE FOR SALE IN THE U.S.
|Display||109 mm Touch LCD Screen|
|Method||One Step Sandwich Reaction|
|Sample Type||Whole Blood and Plasma|
|Sample Volume||500 μL|
|Printer||Built-in Thermal Printer|
|Time to Result||20 min*|
|Dimension (mm)||175 (W) x 330 (D) x 180 (H)|
* For IB10 sphingotest® DPP3 the time to result is 22 minutes.
Watch our short video tutorial and get more information and insight on our rapid point-of-care platform Nexus IB10. Learn in only one and a half minutes how the easy-to-use platform provides test results in only 20 minutes for biomarkers that are crucial in the management of critical care patients.
Products based on the Nexus IB10 technology (Nexus Dx, Inc., San Diego, CA, USA) described are CE-IVD-marked and hence certified and approved for use in the European Economic Area (EEA) only. Human diagnostic use of such products may be subject to local regulations. Please check for local availability and information on potential EEA-external approvals with the manufacturers.
Caution - The information contained in this communication does not constitute nor imply an offer to sell or transfer any product based on the Nexus IB10 technology as in vitro diagnostic (IVD) product in the United States of America or Canada. No product based on the Nexus IB10 technology is currently available for sale as an IVD product in the United States of America or Canada. The analytical and clinical performance characteristics in compliance with U.S. FDA medical device regulations of any Nexus IB10 product may be sold at some future point in time in the U.S., have not yet been established.